Atlas Trials

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

Clinical trial NCT01829178 · COMPLETED

Trial details

NCT number
NCT01829178
Sponsor
Tehran University of Medical Sciences
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Upper GI CancerCisplatin Adverse Reaction
Start date
2013-08-01
Primary completion
2014-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.